Company Filing History:
Years Active: 2005-2018
Title: Innovations of Dean Franklin Rigel
Introduction
Dean Franklin Rigel is a notable inventor based in Berkeley Heights, NJ (US). He has made significant contributions to the field of pharmaceuticals, holding a total of five patents. His work primarily focuses on developing innovative compounds that have therapeutic applications.
Latest Patents
Among his latest patents, Rigel has developed substituted bisphenyl butanoic phosphonic acid derivatives as NEP inhibitors. The present invention provides a compound of formula I, or a pharmaceutically acceptable salt thereof, wherein R, R, and R are defined herein. The invention also relates to a method for manufacturing the compounds and their therapeutic uses. Furthermore, it provides pharmaceutical compositions of the compounds and combinations of pharmacologically active agents with a compound of the invention.
Career Highlights
Dean Franklin Rigel is currently associated with Novartis AG, a leading global healthcare company. His work at Novartis has allowed him to contribute to the advancement of medical science through innovative drug development.
Collaborations
Rigel has collaborated with notable colleagues, including David Weninger Barnes and Scott Louis Cohen. These collaborations have further enhanced the impact of his inventions in the pharmaceutical industry.
Conclusion
Dean Franklin Rigel's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his importance as an inventor. His work continues to influence therapeutic advancements in medicine.